GOVX Geovax Labs Inc

$GOVX Any chart with a RSI at 22 is considered "Oversold".. and GOVX has been oversold for a couple of weeks now. Worth watching or averaging in. No one rings a bell to alert traders/investors that any stock is going to move off its lows and go into a Bottom Reversal, but GOVX has eyeballs on it from the likes of Merck $MRK and $LLY . JMO

$GOVX so this stock is supposed to finally take off now that there is a pandemic in Russia?

$GOVX Sometime I feel like they all connected with each other. Anyway infectious disease stocks should run huge imo. Only 10M float and they need to dilute as well as plague cases in Russia. I connected the dots. Analyst pt $10 with buy rating 🦊🦊🦊🦊🦊🦊🦊🚀🚀🚀🚀

If you like to find the runners early - Join the group of bulls below One of the best FREE small cap communities i know of 🔥 🫡💯 All in on $GOVX $TNXP

$GOVX they are monitoring the situation and will soon work towards thw cure. This can fly

$GOVX before this latest news, $GOVX reported preclinical data for MVA-X --- a single dose produced durable protection in animal models, including against Clade I mpox. If validated in the clinic, transitioning from a two-dose regimen toward single-dose vaccination deployment during future virus outbreaks has the potential to fundamentally change the response by public health organizations.

$GOVX If there is more bad news on this vaccine front, GOVX will probably be getting calls from the Feds and/or Big Pharma Basically, more reports of U.S. Clade Ib transmission could strengthen the long-term mpox vaccine market. GOVX's GEO-MVA’s Phase 3 is pending and is an obvious news catalyst coming. JMO

$GOVX always short the splits. Its a nothing burger. Dodds retirement ponzi scheme. Dixie boii grifter 😂. Jokes on the investors.

$GOVX $GOV News today from GOVX is more important than how the market is reacting to it, imo GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial The agreement represents an important step in the continued development of GEO-MVA, GeoVax's MVA-based vaccine candidate targeting mpox and smallpox. It provides access to independent laboratory testing using standardized assays and reporting procedures established through CEPI's global laboratory infrastructure....For GeoVax, the agreement also supports a broader strategic objective: building independent scientific evidence necessary to establish GEO-MVA as a potential additional source of MVA-based mpox vaccine supply at a time when outbreaks and preparedness requirements continue to demonstrate the importance of resilient, diversified vaccine capacity. Looks obvious that Geovax is pushing to fast track GEO-MVA. Separately, the stock chart shows "Oversold" with the RSI at 27. JMO